This flies in the face of what is generally agreed to by other MS facilities, that treating MS early provides patients with the
best chance of slowing down the disease process, minimizing the number of releases in RRMS, and mitigating permanent neurological damage. There is no way to predict so-called 'benign' MS, and any neurologist who applies that label at the front end of the disease is doing their patients a huge disservice.